AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5

BACKGROUND: Whilst a large number of malaria antigens are being tested as candidate malaria vaccines, a major barrier to the development of an effective vaccine is the lack of a suitable human adjuvant capable of inducing a strong and long lasting immune response. In this study, the ability of AFCo1...

Descripción completa

Detalles Bibliográficos
Autores principales: Bracho, Gustavo, Zayas, Caridad, Wang, Lina, Coppel, Ross, Pérez, Oliver, Petrovsky, Nikolai
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662867/
https://www.ncbi.nlm.nih.gov/pubmed/19250541
http://dx.doi.org/10.1186/1475-2875-8-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662867/
https://www.ncbi.nlm.nih.gov/pubmed/19250541
http://dx.doi.org/10.1186/1475-2875-8-35

Ejemplares similares